Murray Stewart, M.D., is Executive Vice President, Head of R&D, at Novelion Therapeutics Inc. Previously he was the Chief Medical Officer at GlaxoSmithKline, from April 2014-September 2017. Dr. Stewart joined GSK in 2000 as Associate Director for Clinical Research & Development in the UK and since then has held a variety of positions in GSK he worked in Biopharm, was Therapy Area Head for the Cardiovascular and Metabolic therapy area. He has had extensive clinical development experience and worldwide regulatory interactions. Before joining the pharmaceutical industry, Dr. Stewart worked as a diabetes consultant and senior lecturer and was Consultant Physician/Honorary Senior Lecturer and Head of Clinical Services at the Diabetes Centre, Newcastle upon Tyne in the UK. His research was in lipid metabolism in type-2 diabetes, and he completed his medical training at Southampton Medical School in the UK and is a Fellow of the Royal College of Physicians.
Murray Stewart, MD
Executive Vice President, Head of R&D, at Novelion Therapeutics Inc.